174 related articles for article (PubMed ID: 23927433)
1. Hairy cell leukemia in kidney transplantation: lesson from a rare disorder.
Vinante F; Tomei P; Zaza G; Zamò A; Lupo A
Exp Hematol Oncol; 2013; 2():22. PubMed ID: 23927433
[TBL] [Abstract][Full Text] [Related]
2. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
[TBL] [Abstract][Full Text] [Related]
3. BRAF mutations in hairy-cell leukemia.
Tiacci E; Trifonov V; Schiavoni G; Holmes A; Kern W; Martelli MP; Pucciarini A; Bigerna B; Pacini R; Wells VA; Sportoletti P; Pettirossi V; Mannucci R; Elliott O; Liso A; Ambrosetti A; Pulsoni A; Forconi F; Trentin L; Semenzato G; Inghirami G; Capponi M; Di Raimondo F; Patti C; Arcaini L; Musto P; Pileri S; Haferlach C; Schnittger S; Pizzolo G; Foà R; Farinelli L; Haferlach T; Pasqualucci L; Rabadan R; Falini B
N Engl J Med; 2011 Jun; 364(24):2305-15. PubMed ID: 21663470
[TBL] [Abstract][Full Text] [Related]
4. Genomics of Hairy Cell Leukemia.
Tiacci E; Pettirossi V; Schiavoni G; Falini B
J Clin Oncol; 2017 Mar; 35(9):1002-1010. PubMed ID: 28297625
[TBL] [Abstract][Full Text] [Related]
5. BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
Falini B; Martelli MP; Tiacci E
Blood; 2016 Oct; 128(15):1918-1927. PubMed ID: 27554081
[TBL] [Abstract][Full Text] [Related]
6. Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia.
Andrulis M; Penzel R; Weichert W; von Deimling A; Capper D
Am J Surg Pathol; 2012 Dec; 36(12):1796-800. PubMed ID: 22531170
[TBL] [Abstract][Full Text] [Related]
7. Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.
Itamura H; Ide M; Sato A; Sueoka-Aragane N; Sueoka E; Nishida A; Masunari T; Aoki S; Takizawa J; Suzumiya J; Kimura S
Int J Hematol; 2018 Oct; 108(4):416-422. PubMed ID: 30043333
[TBL] [Abstract][Full Text] [Related]
8. Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.
Zhang R; Wu Y; Wang X; Lu X; Li Y; Li S; Yan X
Int J Med Sci; 2020; 17(3):325-331. PubMed ID: 32132867
[No Abstract] [Full Text] [Related]
9. Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib.
Bailleux C; Robert G; Ginet C; Re D; Thyss A; Sudaka I; Peyrottes I; Hofman P; Auberger P; Peyrade F
Oncoscience; 2015; 2(1):44-9. PubMed ID: 25815361
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.
Wang XJ; Kim A; Li S
Int J Clin Exp Pathol; 2014; 7(7):4323-8. PubMed ID: 25120816
[TBL] [Abstract][Full Text] [Related]
11. An extremely rare case of concurrent
Ghorbani-Aghbolaghi A; Lechpammer M; Ali SF; Ku NK; Dwyre DM; Rashidi HH
Autops Case Rep; 2017; 7(3):13-19. PubMed ID: 29043205
[No Abstract] [Full Text] [Related]
12.
Broccoli A; Bertuzzi C; Fiorentino M; Morigi A; Stefoni V; Agostinelli C; Argnani L; Cavo M; Zinzani PL
Onco Targets Ther; 2019; 12():4807-4812. PubMed ID: 31354304
[TBL] [Abstract][Full Text] [Related]
13. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():31-3, 35-6. PubMed ID: 12091638
[TBL] [Abstract][Full Text] [Related]
14. Belatacept for kidney transplant recipients.
Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment.
Polderdijk MCE; Heron M; Kuipers S; Rijkers GT
Expert Rev Clin Immunol; 2019 Aug; 15(8):857-867. PubMed ID: 31282776
[No Abstract] [Full Text] [Related]
16. [Molecular and therapeutic advances in Hairy cell leukemia].
Balsat M; Cornillon J
Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
[TBL] [Abstract][Full Text] [Related]
17. Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
Maitre E; Paillassa J; Troussard X
Front Oncol; 2022; 12():1068981. PubMed ID: 36620555
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant lymphoproliferative disorder in a heart transplant recipient: a case report.
Sahu MK; Singh SP; Satsangi A; Gogia A; Hote MP; Seth S
Indian J Thorac Cardiovasc Surg; 2023 Sep; 39(5):535-538. PubMed ID: 37609612
[TBL] [Abstract][Full Text] [Related]
19. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
Tiacci E; Schiavoni G; Martelli MP; Boveri E; Pacini R; Tabarrini A; Zibellini S; Santi A; Pettirossi V; Fortini E; Ascani S; Arcaini L; Inghirami G; Paulli M; Falini B
Haematologica; 2013 Apr; 98(4):635-9. PubMed ID: 23349307
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders.
Laurini JA; Aoun P; Iqbal J; Chan W; Greiner TC
Am J Clin Pathol; 2012 Dec; 138(6):877-83. PubMed ID: 23161722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
